arrow_back Back to App

Support for Rare Cancer Day: Raising Awareness and Improving Treatment

This House Resolution aims to designate September 30, 2025, as “Rare Cancer Day” to highlight the challenges faced by patients with rare cancers. Its purpose is to raise awareness and support efforts for earlier diagnosis and more effective treatment. Citizens can expect increased public awareness of rare cancer symptoms, potentially leading to quicker diagnoses and better treatment outcomes.
Key points
Designation of “Rare Cancer Day” to increase public awareness.
Support for research and development of new treatments for rare cancers.
Encouraging collaboration between medical and scientific fields to improve diagnosis.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HRES_732
Sponsor: Rep. Kelly, Mike [R-PA-16]
Process start date: 2025-09-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of September 30, 2025, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HRES_732.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-17.

What are the main provisions?

Key points include:

  • Designation of “Rare Cancer Day” to increase public awareness.
  • Support for research and development of new treatments for rare cancers.
  • Encouraging collaboration between medical and scientific fields to improve diagnosis.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kelly, Mike [R-PA-16].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-21.

CATEGORIES

Health